Hakeem Health
Healthtech company behind HakeemDx, an Arabic and English AI clinical decision support and ambient scribe platform for hospitals; raised USD 1.65 million in May 2026.
Industry: Clinical decision support software | Location: Riyadh, Saudi Arabia | Founded: 2022 | Total Funding: USD 1.65M
About Hakeem Health
Hakeem Health, also referred to as HakeemX Technologies, is a healthtech company founded in 2022 by Bilal Adi and Mohammed Ayyad. Regional coverage describes it as Saudi-based, and one profile says it was founded in the UAE. Its main product is HakeemDx, a clinical decision support platform that connects to hospital systems, including electronic medical records and laboratory platforms, and gives clinicians real-time, evidence-based guidance at the point of care. The guidance draws on the patient's own data from the connected systems. The interface works in Arabic and English, which suits health systems where many clinicians trained abroad and work in English while patients and administrative systems operate in Arabic. The company says its mission is to help clinicians make better decisions faster so that patients receive better care. In comments to Inc. Arabia, chief executive Bilal Adi pointed to clinician burnout, medical errors, fragmented access to knowledge, workforce shortages and insurance pressure as urgent problems, and said AI adoption in healthcare is accelerating, particularly in the Gulf. Hakeem Health sells software as a service on recurring institutional contracts rather than individual subscriptions. Its customers are hospitals, universities and healthcare payers. The company says it addresses a market of more than 2,000 hospitals across Saudi Arabia, the UAE and Egypt; this is the company's own description of its reach and market, and Saudi health system reform under Vision 2030 is cited as a driver of demand for clinical AI. In May 2026 the company announced a USD 1.65 million funding round. Wamda reported that it was led by Saudi investment firm Merak Capital with participation from Sanabil 500, while Sharikat Mubasher described Merak Capital and Sanabil 500 as co-leading it. The stage of the round was not stated. Merak Capital manages more than SAR 3 billion across ten funds covering venture capital, private equity, credit financing and special projects, and venture principal Abdulelah Alshareef framed the investment around improving clinical decision-making and patient outcomes. Hakeem Health says the proceeds will go toward accelerating institutional adoption of its clinical AI platform across GCC hospitals, moving from early hospital deployments toward system-level contracts. The company should not be confused with Hakeem Care, a separate Saudi home-healthcare provider.
Leadership
- Bilal Adi, Co-founder
- Mohammed Ayyad, Co-founder